Insider Transactions in Q2 2024 at Haemonetics Corp (HAE)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 06
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
71,335
-16.44%
|
$6,206,145
$87.38 P/Share
|
Jun 06
2024
|
Simon, Christopher President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
104,516
+19.41%
|
$4,285,156
$41.64 P/Share
|
May 29
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
12,990
-15.84%
|
$1,143,120
$88.22 P/Share
|
May 29
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
8,857
-32.74%
|
$770,559
$87.53 P/Share
|
May 28
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,279
-18.31%
|
$501,505
$95.73 P/Share
|
May 28
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,140
+32.91%
|
-
|
May 28
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
4,510
-12.72%
|
$428,450
$95.73 P/Share
|
May 28
2024
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
14,140
+28.51%
|
-
|
May 28
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-4.13%
|
$73,910
$95.73 P/Share
|
May 28
2024
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,650
+12.34%
|
-
|
May 28
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,758
-20.99%
|
$1,117,010
$95.73 P/Share
|
May 28
2024
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
24,748
+30.65%
|
-
|
May 28
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,736
-11.25%
|
$3,964,920
$95.73 P/Share
|
May 28
2024
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
106,062
+22.23%
|
-
|
May 28
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
4,399
-13.99%
|
$417,905
$95.73 P/Share
|
May 28
2024
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
13,256
+29.65%
|
-
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
686
-3.63%
|
$65,170
$95.11 P/Share
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,555
-7.61%
|
$147,725
$95.08 P/Share
|
May 20
2024
|
Stewart W Strong President, Global Hospital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,241
+9.88%
|
$125,496
$56.57 P/Share
|
May 20
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
987
-4.43%
|
$93,765
$95.08 P/Share
|
May 20
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,604
-4.88%
|
$152,380
$95.08 P/Share
|
May 17
2024
|
Farris Maryanne Maunsell VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
587
+33.91%
|
-
|
May 17
2024
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
2,872
+13.63%
|
-
|
May 17
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-1.82%
|
$26,980
$95.73 P/Share
|
May 17
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,394
+18.77%
|
-
|
May 17
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-3.0%
|
$33,155
$95.73 P/Share
|
May 17
2024
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,089
+11.44%
|
-
|
May 17
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-0.54%
|
$7,220
$95.73 P/Share
|
May 17
2024
|
Roy Galvin President, Global Plasma & BC |
BUY
Grant, award, or other acquisition
|
Direct |
2,872
+27.93%
|
-
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
6,267
+21.94%
|
-
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-1.96%
|
$30,400
$95.73 P/Share
|
May 17
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
822
-4.79%
|
$77,268
$94.82 P/Share
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,178
+11.28%
|
-
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
669
-2.28%
|
$63,555
$95.73 P/Share
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,073
-3.53%
|
$101,935
$95.0 P/Share
|
May 17
2024
|
James D Arecca EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,439
+20.38%
|
-
|
May 17
2024
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,624
+5.23%
|
-
|
May 17
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,037
-1.59%
|
$383,515
$95.73 P/Share
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
733
-4.49%
|
$70,368
$96.04 P/Share
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,929
-5.45%
|
$183,255
$95.47 P/Share
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,410
+11.8%
|
$137,370
$57.6 P/Share
|
May 16
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
985
-3.14%
|
$94,560
$96.14 P/Share
|
May 16
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-1.4%
|
$41,924
$94.8 P/Share
|
May 16
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
770
-4.29%
|
$73,920
$96.14 P/Share
|
May 16
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
263
-1.44%
|
$24,722
$94.8 P/Share
|
May 16
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-1.62%
|
$21,902
$94.8 P/Share
|
May 16
2024
|
James D Arecca EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
351
-2.65%
|
$32,994
$94.8 P/Share
|
May 16
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,907
-0.74%
|
$179,258
$94.8 P/Share
|
May 16
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-2.66%
|
$29,892
$94.8 P/Share
|
May 15
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
241
-1.5%
|
$23,136
$96.49 P/Share
|